The Biologics division of Charles River has been expanding in all the places in which we operate. In the fall of 2017, we announced additional bioassay laboratory space in Erkrath, Germany as well as the establishment of an Analytical Center of Excellence in Shrewsbury, MA. In this month’s newsletter we also talk about additional testing capabilities in Ballina, Ireland and the movement of our Pennsylvania operations to the Devon Park facility, which doubles our laboratory space in this area.
Along with the physical growth of our locations, we are evolving towards becoming a more harmonized and globalized organization that is able to provide solutions for the needs of our diverse and expanding client base. It is important to us to provide a seamless service for clients working at different sites while also ensuring their access to our scientific experts is both easy and rapid.
In order to accomplish this, we have implemented SAP as our common enterprise resource planning (ERP) system, and we are in the process of migrating all of our sites to a common laboratory information management system (LIMS). In November, we restructured our senior management team to make our scientific expertise more readily available to our clients and we have begun a focused expansion and additional training and development of our project management and client service teams. These changes have been the result of extensive interviews with our clients regarding their experience with us and expectations of their partnership with us. We want to ensure that service levels at all of our sites exceed our clients’ expectations and that we continue to focus on being the easiest CRO to work with. Quality and speed are our focus and are reflected in our global biologics testing solutions purpose statement: “Safer Biologics. Faster.” This statement is at the center of our aspirations and is driving our growth and expansion plans while staying true to Charles River’s employees’ mission, “Together, we create healthier lives.”
We look forward to continuing to partner with our clients in 2018 and watching you succeed in your journey to bring treatments and cures to the patients who need them.